Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: much caution is warranted

Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype

(2020) Yoshikazu Inoue et al.   CHEST

Progressive fibrosing interstitial lung disease: treatable traits and therapeutic strategies

(2020) Amornpun Wongkarnjana et al.   CURRENT OPINION IN PULMONARY MEDICINE

Rituximab as a rescue treatment added on mycophenolate mofetil background therapy in progressive systemic sclerosis associated interstitial lung disease unresponsive to conventional immunosuppression

(2020) Javier Narváez et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Plasma mycophenolic acid concentration and the clinical outcome after lung transplantation

(2020) Hiroshi Yabuki et al.   CLINICAL TRANSPLANTATION

Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities

(2020) Peter M George et al.   Lancet Respiratory Medicine

Implementing an interstitial lung disease clinic improves survival without increasing health care resource utilization

(2019) Marcus Povitz et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

(2019) Oliver Distler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Potential of Nintedanib in Treatment of Progressive Fibrosing Interstitial Lung Diseases

(2019) Lutz Wollin et al.   EUROPEAN RESPIRATORY JOURNAL

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

(2019) Kevin R. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial

(2019) Toby M Maher et al.   Lancet Respiratory Medicine

Impact of Azathioprine use in chronic hypersensitivity pneumonitis patients

(2019) André Terras Alexandre et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial

(2017) Peter Saunders et al.   Trials

Usefulness of Cyclophosphamide Pulse Therapy in Interstitial Lung Diseases

(2016) Jonas Christian Schupp et al.   RESPIRATION

Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease

(2016) Justin M. Oldham et al.   RESPIRATORY MEDICINE

Nonspecific Interstitial Pneumonia: What Is the Optimal Approach to Management?

(2016) Jay Ryu et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Management of interstitial lung disease associated with connective tissue disease

(2016) Stephen C Mathai et al.   BMJ-British Medical Journal

Management of interstitial lung disease associated with connective tissue disease

(2016) Stephen C Mathai et al.   BMJ-British Medical Journal

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

(2016) Donald P Tashkin et al.   Lancet Respiratory Medicine

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

(2014) Talmadge E. King et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

(2014) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Animal Models of Fibrotic Lung Disease

(2013) Bethany B. Moore et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

High-Resolution CT Findings in Fibrotic Idiopathic Interstitial Pneumonias With Little Honeycombing: Serial Changes and Prognostic Implications

(2012) Ho Yun Lee et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Monitoring of Nonsteroidal Immunosuppressive Drugs in Patients With Lung Disease and Lung Transplant Recipients

(2012) Robert P Baughman et al.   CHEST

Thiopurine S-Methyltranferase Testing in Idiopathic Pulmonary Fibrosis: A Pharmacogenetic Cost-Effectiveness Analysis

(2010) Jared T. Hagaman et al.   LUNG

Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma

(2008) Edoardo Savarino et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy

(2008) F. Hilberg et al.   CANCER RESEARCH